|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Catabasis Pharmaceuticals, Inc.
| | | Phone: | (617) 349-1971 | Fax: | (617) 273-2637 | Year Established: | 2008 | Main Contact: | Ted Hibben, CBO | | Other Contacts: | Joe Johnston, VP, Regulatory Affairs Andrea Matthews, VP, Corporate Affairs Angelika Fretzen, Ph.D., Senior VP, Product Development Deirdre A. Cunnane, Senior VP & Genral Counsel Andrew Nichols, Ph.D., CSO Joanne M. Donovan, M.D., Ph.D., CMO Jill Milne, Co-Founder & CEO
| | Company Description | Catabasis is a clinically staged company dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. The company has assembled a team of passionate and experienced scientists who are committed to improving the lives of patients. Catabasis has developed a pipeline of molecules that amplify the beneficial effects of omega-3 fatty acids to target the underlying etiologies of a spectrum of complex human diseases. Catabasis’ approach dramatically enhances the therapeutic potential of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), two essential fatty acids found in fish oil, by improving the delivery, potency and efficacy. | |
|
|
|
|
|